RxDoctor Payments Data

Anca Galesanu

Nurse Practitioner · Lawrenceburg, INNPI 1639450596

Payments from drug & device makers

$438in general payments, 2019–2025

Across 30 payments — averaging $14.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$126
  • Novo Nordisk$57
  • Bayer$34
  • Pfizer$30
  • Lilly USA, LLC$25
  • Merck$25
  • plus $142 from 10 others

What the payments were for

  • Food & beverage$438100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$438 in reported general payments places this provider in the 60th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Medicare billing

Part B allowed, 2024
$48,573
Medicare patients
174
Services billed
982

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide29$63,930
EliquisApixaban57$45,362
TrulicityDulaglutide16$26,119
JardianceEmpagliflozin24$22,972
MounjaroTirzepatide13$15,760
Breo ElliptaFluticasone/Vilanterol14$7,957
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$3,344
PaxlovidNirmatrelvir/Ritonavir14$2,794
Rosuvastatin Calcium270$2,739
Celecoxib63$2,577
Levothyroxine Sodium180$1,881
Omeprazole107$1,515
Propranolol Hcl ErPropranolol Hcl26$1,355
Pantoprazole Sodium109$1,320
Atorvastatin Calcium153$1,004

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$57$63,93029 claims
PfizerEliquis, Paxlovid$30$48,15671 claims
Lilly USA, LLCTrulicity, Mounjaro$25$41,87929 claims
Boehringer IngelheimJardiance$13$22,97224 claims
GSKBreo Ellipta$16$7,95714 claims
AbbVieSynthroid$126$99317 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,724 nurse practitioner providers in Indiana.

Other nurse practitioner in Lawrenceburg

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →